A new study finds that the medicine in the diabetes drug Mounjaro helped people with obesity or who are overweight lose at least a quarter of their body weight
October 15, 2023 at 9:04 am PDTFILE - A sign for Eli Lilly & Co. stands outside their corporate headquarters in Indianapolis on April 26, 2017. . The medicine in the diabetes drug Mounjaro helped people with obesity or who are overweight lose at least a quarter of their body weight, or about 60 pounds on average, when combined with intensive diet and exercise, a new study shows.
The results, which were also presented Sunday at a medical conference, confirm that the drug made by Eli Lilly & Co. has the potential to be one of the most powerful medical treatments for obesity to date, outside experts said. All the drugs, which carry retail price tags of $900 a month or more, have been in shortage for months.
After three months of intensive diet and exercise, more than 200 participants left the trial, either because they failed to lose enough weight or for other reasons. The remaining nearly 600 people were randomized to receive tirzepatide or a placebo via weekly injections for about 16 months. Nearly 500 people completed the study.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Drug used in diabetes treatment Mounjaro helped dieters shed 60 pounds, study findsA new study finds that the medicine in the diabetes drug Mounjaro helped people with obesity or who are overweight lose at least a quarter of their body weight.
Baca lebih lajut »
Drug used in diabetes treatment Mounjaro helped dieters shed 60 pounds, study findsA new study finds that the medicine in the diabetes drug Mounjaro helped people with obesity or who are overweight lose at least a quarter of their body weight. That's about 60 pounds on average. The people also did three months of intensive diet and exercise.
Baca lebih lajut »
UnitedHealth earnings beat estimates as company again raises guidanceInsurance giant takes aim at weight-loss drug prices, saying cost will limit adoption
Baca lebih lajut »
Inflation Reduction Act’s Drug Pricing Provisions May Lead To Lower Prices In OncologyI'm an independent healthcare analyst with more than 24 years of experience analyzing healthcare and pharmaceuticals.
Baca lebih lajut »
‘Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdlesTwo experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly’s obesity drugs.
Baca lebih lajut »
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdlesTwo experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly's obesity drugs.
Baca lebih lajut »